| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 604,384 | 1,501,975 | | Cost of Revenue | 3,994 | 238,331 | | | Gross Profit | 600,390 | 1,263,644 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 364,052 | 1,107,346 | | Non Recurring | (4,751) | 3,333,396 | | Others | 1,698,989 |
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (1,457,900) | (3,177,098) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (132,643) | 2,413,246 | | Earnings Before Interest And Taxes | (1,590,543) | (706,473) | | Interest Expense | 33,948 | 24,240 | | Income Before Tax | (1,624,491) | (730,713) | | Income Tax Expense | 40,066 | 63,963 | | Minority Interest | 1,153,961 | (120,350) | | | | Net Income From Continuing Ops | (510,596) | (915,026) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (510,596) | (915,026) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($510,596) | ($915,026) |
|
0.02% Nasdaq 
Income Statement
